Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients

The Journal of Thoracic and Cardiovascular Surgery - Tập 135 Số 3 - Trang 620-626.e3 - 2008
Raja M. Flores1, Harvey I. Pass2, Venkatraman Seshan3, Joseph Dycoco1, Maureen F. Zakowski4, Michele Carbone5, Manjit S. Bains1, Valerie W. Rusch1
1Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Cardiothoracic Surgery, New York University Medical Center, New York, NY
3Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pathology. University of Hawaii, Honolulu, Hawaii,

Tóm tắt

Từ khóa


Tài liệu tham khảo

Flores, 2006, Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial, J Thorac Oncol, 1, 289, 10.1097/01243894-200605000-00004

Weder, 2004, Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma, J Clin Oncol, 22, 3451, 10.1200/JCO.2004.10.071

Sugarbaker, 1999, Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results of 183 patients, J Thorac Cardiovasc Surg, 117, 54, 10.1016/S0022-5223(99)70469-1

Rusch, 1994, A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma, J Clin Oncol, 12, 1156, 10.1200/JCO.1994.12.6.1156

Richards, 2006, Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma, J Clin Oncol, 24, 1561, 10.1200/JCO.2005.04.6813

Rusch, 2001, A Phase II trial of surgical resection and adjuvant high dose hemithoracic radiation for malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 122, 788, 10.1067/mtc.2001.116560

Lee, 2002, Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 124, 1183, 10.1067/mtc.2002.125817

Hilaris, 1984, Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma, Int J Radiat Oncol Biol Phys, 10, 325, 10.1016/0360-3016(84)90050-6

McCormack, 1982, Surgical treatment of pleural mesothelioma, J Thorac Cardiovasc Surg, 84, 834, 10.1016/S0022-5223(19)38932-9

Pass, 1997, Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma, Ann Surg Oncol, 4, 628, 10.1007/BF02303746

Lu, 2005, Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma, J Clin Oncol, 23, 3495, 10.1200/JCO.2005.00.802

Allen, 1994, Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy, Chest Surg Clin N Am, 4, 113

Rusch, 1991, The role of extrapleural pneumonectomy in malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 102, 1, 10.1016/S0022-5223(19)36577-8

Stewart, 2004, The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma, Ann Thorac Surg, 78, 245, 10.1016/j.athoracsur.2004.01.034

2002, American Joint Committee on Cancer

Yajnik, 2003, Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma, Int J Radiat Oncol Biol Phys, 56, 1319, 10.1016/S0360-3016(03)00287-6

Gupta, 2005, Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma, Int J Radiat Oncol Biol Phys, 63, 1045, 10.1016/j.ijrobp.2005.03.041

Battifora, 2003

Flores, 2003, Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 126, 11, 10.1016/S0022-5223(03)00207-1

Flores, 2006, Positron emission tomography (PET) predicts survival in malignant pleural mesothelioma (MPM), J Thorac Cardiovasc Surg, 132, 763, 10.1016/j.jtcvs.2006.03.068

Rusch, 1999, Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically, Ann Thorac Surg, 68, 1799, 10.1016/S0003-4975(99)01038-3

Byrne, 1999, Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study, J Clin Oncol, 17, 25, 10.1200/JCO.1999.17.1.25

Van Meerbeeck, 2005, J Clin Oncol, 23, 6881, 10.1200/JCO.20005.14.589

Vogelzang, 2003, Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma, J Clin Oncol, 21, 2636, 10.1200/JCO.2003.11.136